A 22-plex chemiluminescent microarray for pneumococcal antibodies

American Journal of Clinical Pathology

Volumn 128, Issue 1, 2007, Pages 23-31

  Pickering, Jerry W ^a   Hoopes, Justin D ^b   Groll, Matthew C ^b   Romero, Heidi K ^a   Wall, Dave ^a   Sant, Howard ^a   Astill, Mark E ^a   Hill, Harry R ^a,c  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b Spendlove Research Foundation   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

ELISA; Enzyme linked immunosorbent assay; IgG; Microarray; Pneumococcal; Polysaccharide; Vaccine

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; 23 VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CELL CULTURE; CHEMOLUMINESCENCE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENICITY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; BLOOD; IMMUNOLOGY; METHODOLOGY; PROTEIN MICROARRAY;

ANTIBODIES, BACTERIAL; CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; PNEUMOCOCCAL VACCINES; PROTEIN ARRAY ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 34547127875     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/781K5W6QH7JH2TMA     Document Type: Article

References (33)

1. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992;14:801-809.
2. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
3. Goldblatt D, Hyssain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192:387-393.
4. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002;185:927-936.
5. Cooper MD, Lanier LL, Conley ME, et al. Immunodeficiency disorders. Hematology Am Soc Hematol Educ Prog. 2003:314-330.
6. Rijkers GT, Sanders LA, Zegers BJ. Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency. 1993;5:1-21.
7. Picard C, Puel A, Bustamante J, et al. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol. 2003;3:451-459.
8. Ambrosino DM, Siber GR, Chilmonczyk BA, et al. Immunodeficiency characterized by impaired antibody response to polysaccharides. N Engl J Med. 1987;316:790-793.
9. Hidalgo H, Moore C, Leiva LE, et al. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol. 1996;76:341-346.
10. Epstein MM, Gruskay F. Selective deficiency in pneumococcal antibody in children with recurrent infections. Ann Allergy Asthma Immunol. 1995;75:125-131.
11. Cheng YK, Decker PA, O'Byrne MM, et al. Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome. Ann Allergy Asthma Immunol. 2006;97:306-311.
12. Jeurissen A, Boudewijns M, Proesmans M, et al. Evaluation of the immune response to pneumococcal capsular polysaccharides. Acta Clin Belg. 2003;58:106-110.
13. Wasserman R, Sorensen RU. Evaluating children with respiratory tract infections: the role of immunization with bacterial polysaccharide vaccine. Pediatr Infect Dis J. 1999;18:157-163.
14. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2000;49:1-38.
15. Black S, Shinefield HR, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
16. Pickering JW, Martins TM, Greer RC, et al. A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am J Clin Pathol. 2001;117:589-596.
17. Biagini RE, Schlottmann SA, Sammons DL, et al. Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin Diagn Lab Immunol. 2003;10:744-750.
18. Lal G, Balmer P, Stanford E, et al. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Methods. 2005;296:135-147.
19. Schlottmann SA, Jain N, Chirmule N, et al. A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres. J Immunol Methods. 2006;309:75-85.
20. Quataert SA, Kirch CS, Wiedl LJQ, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin Diagn Lab Immunol. 1995;2;590-592.
21. Quataert SA, Rittenhouse-Olsen K, Kirch CS, et al. Assignment of weight-based units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(F). Clin Diagn Lab Immunol. 2004;11:1064-1069.
22. Wernette CM, Frasch CE, Madore DM, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol. 2003;10:514-519.
23. Jodar L, Butler J, Carlone G, et al. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine. 2003;21:3265-3272.
24. World Health Organization. Training Manual for Enzyme Linked Immunosorbent Assay for the Quantitation of Streptococcus pneumoniae Serotype-Specific IgG (PN PS ELISA). 2004. Available at http://www.vaccine.uab.edu/. Accessed May 8, 2007.
25. Goldblatt D, Levinsky RJ, Turner MW. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharide of Streptococcus pneumoniae in childhood. J Infect Dis. 1992;166:632-643.
26. Musher DM, Luchi MJ, Watson DA, et al. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990;161:728-735.
27. Soininen A, Van Den Dobbelsteen G, Oomen L, et al. Are enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype-specific? Clin Diagn Lab Immunol. 2000;7:468-476.
28. Yu X, Sun Y, Frasch C, et al. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic. Clin Diagn Lab Immunol. 1999;6:519-524.
29. Concepcion NF, Frasch CE. Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2001;8:266-272.
30. Marchese RD, Jain NT, Antonello J, et al. Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay. Clin Vaccine Immunol. 2006;13:905-912.
31. Go ES, Ballas ZK. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol. 1996;98:205-215.
32. Musher DM, Groover JE, Watson DA, et al. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal polysaccharides. J Investig Med. 1997;45:57-68.
33. Sorensen RU, Moore C. Antibody deficiency syndromes. Pediatr Clin North Am. 2000;47:1-23.